CPL @1112 (52.3%) on 19-jul-2018 [ "_ is a prescription medication" "post-approval use of _" "drug type ยป _" "arthritis patients taking _" "prescription drug , such as _" "nursing infants from _" "new drug is called _" "meds , such as _" "I was just prescribed _" "expensive drugs like _" "_ is an injectable drug" "drugs such as _" "dangerous drugs like _" "Community Ask patient community about _" "such drugs as _" "medications similar to _" "Drug interactions of _" "review Below are _" "shared decision about _" "_ is already FDA-approved" "drug review Below are _" "_ read the NOTE." "adverse event reports related to _" "drug interactions between _" "_ 's safety profile" "_ also inhibits the activity" "_ is a great drug" "provider recommends taking _" "_ is a wonderful medication" "Drug interactions analysis of _" "prescription drugs like _" "certain drugs such as _" "drugs , such as _" "opioids , such as _" "View drug information on _" "TNF-blocking agents , including _" "Breast-feeding-It is not known whether _" "other drugs , such as _" "pain killer such as _" "serious side effect of _" "_ is considered a pregnancy Category B medication" "drugs , like _" "drug called _" "medications such as _" "_ was the only drug" "new medication called _" "clinical trials possibly related to _" "generic biologics , including generic _" "interactions analysis of _" "trials possibly related to _" "drug , called _" "immunosuppressants such as _" "similar drugs like _" "antagonists , such as _" "Common side effects with _" "patients do n't respond to _" "prescription drug like _" "Well-designed clinical trials possibly related to _" "arthritis medications such as _" "_ does cross the placenta" "medication called _" "healthcare provider recommends taking _" "drugs like _" "biologics , including generic _" "Ask patient community about _" "drugs , including _" "event reports related to _" "_ is a similar drug" "narcotics such as _" "drug similar to _" "patient community about _" "_ is a monoclonal antibody" "_ goes off-patent" "you have reacted badly to _" ] using humira
SEAL @111 (99.2%) on 02-jun-2010 [ 1234567 ] using humira
CPL @1100 (92.3%) on 30-jan-2018 [ "TNF-blocking agents , including _" "nursing infants from _" "patient was treated with _" "_ is a prescription medicine" "same period patient was treated with _" "period patient was treated with _" "common side effects with _" "Common side effects with _" "violative promotional materials for _" ] using humira
CPL @1099 (91.0%) on 22-jan-2018 [ "first dose of _" "infections include _" "mon side effects of _" "side affects of _" "drugs such as _" "dose of _" "side effects with _" "bad reaction to _" "_ was the drug" "side effects from _" "side effects of _" "drugs like _" "adverse reactions from _" "aspirin with _" "medications including _" "infections by _" "drug like _" "drug , generic _" "treatment with _" "codeine with _" "injections of _" "inhibitors such as _" "_ is not the drug" "possible side effects of _" ] using humira
SEAL @556 (50.0%) on 22-apr-2012 [ 1 ] using (humira, abbott_laboratories)
CPL @1095 (87.5%) on 17-jan-2018 [ "arg2 Laboratories as arg1" "arg2 received FDA approval for arg1" "arg2 Laboratories announced that arg1" ] using (humira, abbott)
SEAL @263 (75.0%) on 22-may-2011 [ 12 ] using (humira, abbott)
CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" "arg1 marketed by arg2" ] using (humira, abbott_laboratories)
NELL has only weak evidence for items listed in grey
SEAL @556 (50.0%) on 22-apr-2012 [ 1 ] using (humira, abbott_laboratories)
CPL @1095 (87.5%) on 17-jan-2018 [ "arg2 Laboratories as arg1" "arg2 received FDA approval for arg1" "arg2 Laboratories announced that arg1" ] using (humira, abbott)
SEAL @263 (75.0%) on 22-may-2011 [ 12 ] using (humira, abbott)
CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" "arg1 marketed by arg2" ] using (humira, abbott_laboratories)
CPL @1095 (87.5%) on 17-jan-2018 [ "arg2 Laboratories as arg1" "arg2 received FDA approval for arg1" "arg2 Laboratories announced that arg1" ] using (humira, abbott)
SEAL @263 (75.0%) on 22-may-2011 [ 12 ] using (humira, abbott)
CPL @1095 (87.5%) on 17-jan-2018 [ "arg2 Laboratories as arg1" "arg2 received FDA approval for arg1" "arg2 Laboratories announced that arg1" ] using (humira, abbott)
SEAL @263 (75.0%) on 22-may-2011 [ 12 ] using (humira, abbott)
CPL @1095 (87.5%) on 17-jan-2018 [ "arg2 Laboratories as arg1" "arg2 received FDA approval for arg1" "arg2 Laboratories announced that arg1" ] using (humira, abbott)
SEAL @263 (75.0%) on 22-may-2011 [ 12 ] using (humira, abbott)